- A. Health Biotechnology
- Areas of activity
- Therapeutic areas
- Blood and lymphatic system
- Metabolic disorders / Endocrinology
Novo Nordisk is a global health care company with 95 years of innovation and leadership in diabetes care. This inheritance has given him the appropriate experience and ability to help people suffering from obesity, hemophilia, growth disorders and other serious chronic diseases. Novo Nordisk is headquartered in Denmark, employs about 42,100 people in 79 countries and markets its products in more than 170 countries.